No improvement in long-term survival over time for chronic lymphocytic leukemia patients in stereotyped subsets #1 and #2 treated with chemo(Immuno)therapy

Additional Metadata
Persistent URL	doi.org/10.3324/haematol.2017.182634, hdl.handle.net/1765/105514
Journal	Haematologica
Grant	This work was funded by the European Commission 7th Framework Programme; grant id h2020/692298 - Medical Genomics and Epigenomics Network (MEDGENET)
Organisation	Department of Immunology
Citation APA APA Style APA-ALL Style AAA Style Cell Style Chicago Style Harvard Style IEEE Style MLA Style Nature Style Vancouver Style American-Institute-of-Physics Style Council-of-Science-Editors Style BibTex Format Endnote Format RIS Format CSL Format DOIs only Format	Baliakas, P., Mattsson, M. (Mattias), Hadzidimitriou, A., Minga, E., Agathangelidis, A. (Andreas), Sutton, L., Scarfó, L., Davis, Z., Yan, X.-J. (Xiao-Jie), Plevova, K., Sandberg, Y., Vojdeman, F. J., Tzenou, T., Chu, C.C. (Charles C.), Veronese, S., Mansouri, A., Smedby, O., Giudicelli, V., Nguyen-Khac, F., … Stamatopoulos, K. (2018). No improvement in long-term survival over time for chronic lymphocytic leukemia patients in stereotyped subsets #1 and #2 treated with chemo(Immuno)therapy. Haematologica, 103(4), e158–e161.https://doi.org/10.3324/haematol.2017.182634

Publication